SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John H. Farro who wrote (4165)2/5/1999 6:36:00 PM
From: A.R.Venkatesh  Read Replies (1) of 4342
 
Robin, I think you
may be right about prdeiction (3). But I would put it 50/50 because it is binary in nature, either it happens or it does not happen.
It may not happen because large pharmaceuticals are not interested in replacing(revenues of) multi-drug therapies with that of a single one(if that is the case). If I recollect correctly Paracelsian's drug works in conjunction with other drugs. Anyway we have SRI on Paracelsian's side and more importantly Travellers Insurance(an investor) will be very interested in getting remedial therapy to the AIDS virus. I believe that Travellers insurance together with SRI & Paraclesian can influence a major Pharmaceutical to sign on. I think this solution has already been proven once
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News